EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1

Dongdong Xie iD, Yu Wang, Wenjie Cheng, Minbo Yan, Kunyu Li, Xiang Wu, Jiaqing Wu, Zhuangzhuang Zhang, Yingbo Dai iD

Cell Proliferation · 2026-03 · 59 (3)

DOI: 10.1111/cpr.70101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 31.07.2025. Verfasst von Dongdong Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Cuproptosis, Thiamine, Hydrazines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a copper‐dependent cell death mechanism driven by tricarboxylic acid (TCA) cycle collapse, shows limited efficacy in hypoxic or glycolytic renal cell carcinoma (RCC). Here, through systematic screening of 688 glycolysis inhibitors combined with elesclomol (ES), we identified PIK‐III as a potent cuproptosis sensitiser. Multi‐omics analysis revealed that PIK‐III restores sensitivity by rewiring thiamine metabolism. Mechanistically, PIK‐III induces macropinocytosis, enabling thiamine uptake to replenish thiamine pyrophosphate (TPP), which activates pyruvate dehydrogenase E1‐alpha 1 (PDHA1) and redirects pyruvate into the TCA cycle. Concurrently, ES‐induced DLAT oligomerisation disrupts TCA flux, creating a metabolic crisis. In vivo, PIK‐III synergises with ES to suppress tumour growth in xenograft and patient‐derived models without systemic toxicity. Our work uncovers a metabolic vulnerability in cuproptosis‐resistant RCC and positions PIK‐III as a therapeutic candidate to overcome resistance via dual targeting of thiamine transport and mitochondrial dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellCuproptosisThiamineHydrazinesGlycolysisMultiomicsPinocytosisPyruvate Dehydrogenase (Lipoamide)Citric Acid CycleHumansAnimalsXenograft Model Antitumor AssaysCell Line, TumorMice, Inbred BALB CAntineoplastic AgentsOxidative Stress

Stichwörter der Autor:innen

PIK‐IIIWarburg effectccRCCcuproptosisthiamine metabolism

Substanzen

Thiaminepyruvate dehydrogenase E1alpha subunitPyruvate Dehydrogenase (Lipoamide)elesclomolHydrazinesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
  • Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
  • Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
  • Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Dongdong Xie, Yingbo Dai

Förderung

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Xie, D., Wang, Y., Cheng, W., Yan, M., Li, K., Wu, X., Wu, J., Zhang, Z., & Dai, Y. (2026). PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1. Cell Proliferation, 59(3). https://doi.org/10.1111/cpr.70101

Vancouver

Xie D, Wang Y, Cheng W, Yan M, Li K, Wu X, et al. PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1. Cell Proliferation. 2026;59(3). doi:10.1111/cpr.70101

BibTeX
@article{Xie2026,
  author = {Xie, Dongdong and Wang, Yu and Cheng, Wenjie and Yan, Minbo and Li, Kunyu and Wu, Xiang and Wu, Jiaqing and Zhang, Zhuangzhuang and Dai, Yingbo},
  title = {PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {3},
  doi = {10.1111/cpr.70101}
}
Kostenlos starten →